Last Updated on September 1, 2021 by The Health Master
Granules India Limited has received marketing approval from Health Canada for acetaminophen extended-release tablets OTC, 650mg for the treatment of arthritis pain.
The product manufactured by Granules is a bioequivalent to the reference listed drug, Tylenol extended release 650 tablets.
Priyanka Chigurupati, executive director of Granules USA, Inc. & Granules Pharmaceuticals, Inc. said, “We received the approval within eight months of filing. This is a step towards global expansion of our core molecules.
The approval of acetaminophen extended-release tablets OTC, 650mg, a complex Bi-layer extended released based formulations, is a good addition to our portfolio. We will be launching the product in the Canada market soon.”
The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad. Granules now have a total of 2 ANDS approvals from Health Canada.
Aurobindo Pharma gets USFDA nod for cancer treatment drug
USFDA approves drug for severe Itching in kidney disease patients
Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets
GSK gets USFDA nod for Jemperli to treat advanced solid Tumours
Lupin gets tentative USFDA nod for Brivaracetam tablets
Zydus Cadila gets USFDA nod for Mesalamine ER capsules
Indian Pharma exports: Oceania a potential region: Pharmexcil
Drug recall: Dr Reddy’s & Zydus Pharma Recall these drugs
DCGI approves 3 FDCs containing Cefixime & Cefadroxil as rational
CDSCO issues procedure for regulation of 19 FDCs out of 294
Novel antibiotic Nafithromycin for respiratory track infection
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
